Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-312024-04-01false33truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 03877524 2024-04-01 2025-03-31 03877524 2023-04-01 2024-03-31 03877524 2025-03-31 03877524 2024-03-31 03877524 c:Director3 2024-04-01 2025-03-31 03877524 d:PatentsTrademarksLicencesConcessionsSimilar 2024-04-01 2025-03-31 03877524 d:PatentsTrademarksLicencesConcessionsSimilar 2025-03-31 03877524 d:PatentsTrademarksLicencesConcessionsSimilar 2024-03-31 03877524 d:CopyrightsPatentsTrademarksServiceOperatingRights 2024-04-01 2025-03-31 03877524 d:CopyrightsPatentsTrademarksServiceOperatingRights 2025-03-31 03877524 d:CopyrightsPatentsTrademarksServiceOperatingRights 2024-03-31 03877524 d:CurrentFinancialInstruments 2025-03-31 03877524 d:CurrentFinancialInstruments 2024-03-31 03877524 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 03877524 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 03877524 d:ShareCapital 2025-03-31 03877524 d:ShareCapital 2024-03-31 03877524 d:RetainedEarningsAccumulatedLosses 2025-03-31 03877524 c:OrdinaryShareClass1 2024-04-01 2025-03-31 03877524 c:OrdinaryShareClass1 2025-03-31 03877524 c:FRS102 2024-04-01 2025-03-31 03877524 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 03877524 c:FullAccounts 2024-04-01 2025-03-31 03877524 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 03877524 2 2024-04-01 2025-03-31 03877524 6 2024-04-01 2025-03-31 03877524 e:PoundSterling 2024-04-01 2025-03-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 03877524









MILLENNIUM DIET & NUTRICEUTICALS LIMITED

UNAUDITED

FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2025

 
MILLENNIUM DIET & NUTRICEUTICALS LIMITED
REGISTERED NUMBER: 03877524

BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
Note
£
£

Fixed assets
  

Investments
 5 
183,902
192,465

Current assets
  

Cash at bank
  
5,501
5,395

Current liabilities
  
5,501
5,395

Creditors: amounts falling due within one year
 6 
(1,543)
(1,438)

Net current assets
  
 
 
3,958
 
 
3,957

  

Net assets
  
187,860
196,422


Capital and reserves
  

Called up share capital 
 7 
100
100

Profit and loss account
  
187,760
196,322

  
187,860
196,422


Page 1

 
MILLENNIUM DIET & NUTRICEUTICALS LIMITED
REGISTERED NUMBER: 03877524

BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 






................................................
Mr J L Howard
Director

Date: 1 July 2025

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
MILLENNIUM DIET & NUTRICEUTICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


GENERAL INFORMATION

Millennium Diet & Nutriceuticals Limited is a private Company limited by shares, incorporated in England and Wales within the United Kingdom. The address of the registered office is 65 The Belvedere, Homerton Street, Cambridge, CB2 0NT. This Company is not part of a group.

2.ACCOUNTING POLICIES

 
2.1

BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

VALUATION OF INVESTMENTS

Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

 
2.3

CASH AND CASH EQUIVALENTS

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 3

 
MILLENNIUM DIET & NUTRICEUTICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.ACCOUNTING POLICIES (CONTINUED)

 
2.4

FINANCIAL INSTRUMENTS

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

The Company has elected to apply the recognition and measurement provisions of IFRS 9 Financial Instruments (as adopted by the UK Endorsement Board) with the disclosure requirements of Sections 11 and 12 and the other presentation requirements of FRS 102.

Financial instruments are recognised in the Company's Balance Sheet when the Company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Other financial assets

Other financial assets, which includes investments in equity instruments which are not classified as subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the recognised transaction price. Such assets are subsequently measured at fair value with the changes in fair value being recognised in the profit or loss. Where other financial assets are not publicly traded, hence their fair value cannot be measured reliably, they are measured at cost less impairment.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Page 4

 
MILLENNIUM DIET & NUTRICEUTICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.ACCOUNTING POLICIES (CONTINUED)

 
2.5

CREDITORS

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.6

FOREIGN CURRENCY TRANSLATION

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

 
2.7

PENSIONS

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.8

INTEREST INCOME

Interest income is recognised in profit or loss using the effective interest method.

Page 5

 
MILLENNIUM DIET & NUTRICEUTICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.ACCOUNTING POLICIES (CONTINUED)

 
2.9

TAXATION

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.



3.


EMPLOYEES

The average monthly number of employees, including directors, during the year was 3 (2024 - 3).

Page 6

 
MILLENNIUM DIET & NUTRICEUTICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

4.


INTANGIBLE ASSETS




Patents
Trademarks
Total

£
£
£





At 1 April 2024
59,737
4,374
64,111


Disposals
(59,737)
(4,374)
(64,111)



At 31 March 2025

-
-
-





At 1 April 2024
59,737
4,374
64,111


On disposals
(59,737)
(4,374)
(64,111)



At 31 March 2025

-
-
-



Net book value



At 31 March 2025
-
-
-



At 31 March 2024
-
-
-




5.


FIXED ASSET INVESTMENTS





Listed investments

£



Valuation


At 1 April 2024
192,466


Additions
2,632


Disposals
(3,273)


Revaluations
(7,923)



At 31 March 2025
183,902





6.


CREDITORS: Amounts falling due within one year

2025
2024
£
£

Accruals
1,543
1,438


Page 7

 
MILLENNIUM DIET & NUTRICEUTICALS LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

7.


SHARE CAPITAL

2025
2024
£
£
Allotted, called up and fully paid



100 (2024 - 100) Ordinary shares of £1.00 each
100
100



8.


PENSION COMMITMENTS

The Company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £10,000 (2024 - £33,000). No contributions (2024 - £Nil) were payable to the fund at the balance sheet date. 


Page 8